These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16792913)

  • 1. [Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers].
    Liu F; Feys HB; Dong NZ; Bai X; Vanhoorelbeke K; Deckmyn H; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):154-7. PubMed ID: 16792913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical study of congenital thrombotic thrombocytopenic purpura].
    Liu F; Dong NZ; Jin J; Hendrik FB; Bai X; Ruan CG
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):482-4. PubMed ID: 16831327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
    Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
    Starke R; Machin S; Scully M; Purdy G; Mackie I
    Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
    Cataland SR; Jin M; Lin S; Kennedy MS; Kraut EH; George JN; Wu HM
    Br J Haematol; 2007 Nov; 139(3):486-93. PubMed ID: 17910638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
    Manea M; Kristoffersson A; Tsai HM; Zhou W; Winqvist I; Oldaeus G; Billström R; Björk P; Holmberg L; Karpman D
    Eur J Pediatr; 2007 Mar; 166(3):249-57. PubMed ID: 17187257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of ADAMTS13 antigen determined with an enzyme immunoassay using a neutralizing monoclonal antibody parallel ADAMTS13 activity LevEls.
    Yagi H; Ito S; Kato S; Hiura H; Matsumoto M; Fujimura Y
    Int J Hematol; 2007 Jun; 85(5):403-7. PubMed ID: 17562615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.
    Lotta LA; Valsecchi C; Pontiggia S; Mancini I; Cannavò A; Artoni A; Mikovic D; Meloni G; Peyvandi F
    J Thromb Haemost; 2014; 12(3):329-36. PubMed ID: 24354764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
    Connell NT; Cheves T; Sweeney JD
    Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.
    Wu N; Liu J; Yang S; Kellett ET; Cataland SR; Li H; Wu HM
    Transfusion; 2015 Jan; 55(1):18-24. PubMed ID: 24953079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
    Thomas MR; de Groot R; Scully MA; Crawley JT
    EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences.
    Feys HB; Liu F; Dong N; Pareyn I; Vauterin S; Vandeputte N; Noppe W; Ruan C; Deckmyn H; Vanhoorelbeke K
    J Thromb Haemost; 2006 May; 4(5):955-62. PubMed ID: 16689741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of von Willebrand factor pro-peptide and ADAMTS13 in diagnosis of thrombotic thrombocytopenic purpura].
    Ji J; Liu T; Meng WT; Lu ZP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):807-10. PubMed ID: 22332547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired TTP: ADAMTS13 meets the immune system.
    Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
    Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpura.
    Dwyre DM; Dursteler B; Nashelsky M; Friedman KD; Raife TJ
    J Clin Apher; 2009; 24(3):106-10. PubMed ID: 19253359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
    Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and clinical application of a new method for detecting ADAMTS13 activity.
    Wang AY; Dong NZ; Ma ZN; Zhang JY; Su J; Ruan CG
    Chin Med J (Engl); 2010 Jul; 123(14):1859-63. PubMed ID: 20819568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.